Related Experiment Videos

The Kirby Institute-ending HIV transmission in Australia

The Lancet. HIV

|July 1, 2022

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care.

The lancet. HIV·2026

Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.

The lancet. HIV·2026

Targeted point-of-care HIV testing at birth for newborns at high risk of vertical transmission in Botswana: a prospective cohort study.

The lancet. HIV·2026

Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa.

The lancet. HIV·2026

Epidemiology and management of HIV-2.

The lancet. HIV·2026

Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.

The lancet. HIV·2026

See all related articles